Strobel, K., Dhamane, A. D., Li, J. B., Tinel, A., Schilling, S., Rückert, M., Weißinger, F. (2025). Lenalidomide (LEN) and anti-CD38 monoclonal antibodies (mAbs) utilization in patients with newly diagnosed and relapsed/refractory multiple myeloma (MM) in Germany: Real-world insights on epidemiology and clinical outcomes. Blood. https://doi.org/10.1182/blood-2025-4568